Cefepime Hydrochloride/Taniborbactam
- Generic Name
- Cefepime Hydrochloride/Taniborbactam
Cefepime-taniborbactam Vs Meropenem in Adults with VABP or Ventilated HABP
Phase 3
Withdrawn
- Conditions
- Ventilator-associated PneumoniaHospital-acquired Pneumonia
- Interventions
- First Posted Date
- 2023-12-13
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 316
- Registration Number
- NCT06168734
Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects
- First Posted Date
- 2021-07-06
- Last Posted Date
- 2021-10-01
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04951505
- Locations
- 🇺🇸
Pulmonary Associates PA, Phoenix, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath